Lunchtime Networking Event, Hosted by FTI Consulting
The next edition of our 'Lunchtime Networking Event' series is being hosted by the team at FTI Consulting at the Beehouse on Milton Park on Thursday 12th June 2025.
In addition to lunch and networking, the session will feature expert speakers who will provide updates, advice and strategic solutions for some of the tax hurdles that R&D SMEs can face.
Presentations and workshop sessions will cover Tax Issues and Opportunities in Licensing and Collaboration, Share Schemes and Employment Tax and new rules for R&D Tax Incentives. The event will include a delicious lunch over networking and the opportunity to meet with senior members of the FTI Consulting and Field Fisher team on a 1:1 basis.
Draft Programme:
11.15 โ 11.30 Guest arrival, registration & networking
11.30 โ 11:45 Welcome from the FTI Consulting team
11:45 โ 12:30 Keynote presentation and Q&A on 'Tax Issues and Opportunities in Licensing and Collaboration'
- Richard Turner, Senior Managing Director, FTI Consulting
- Janita Good, Partner, Field Fisher
12.30 โ 13.15 Networking lunch
13.15 โ 14:00 Workshop One: 'Share Schemes and Employment Tax in Biotechnology'
- Lewin Higgins-Green, Senior Managing Director, FTI Consulting
14:00 โ 14:45 Workshop Two: 'Practical Insights and Best Practice for Life Sciences R&D Claims'
- Richard Turner, Senior Managing Director, FTI Consulting
14.45 โ 17.00 One-One partnering meetings in breakout room (or guests free to depart)
Who should attend:
This event is designed for professionals in the life sciences industry interested in accessing the expert FTI Consulting Life Sciences tax team whose in-depth knowledge and advice can support with structuring, mitigating tax risk and optimising incentives.
The event is complimentary and available on an 'apply to attend' basis.
About FTI Consulting
FTI Consulting works with the healthcare and life sciences industry to discern innovative solutions that optimise performance in the short term and prepare for future strategic, operational, financial and legal challenges. Specifically in the area of Life Sciences, our team offers in-depth knowledge of the financial, operational and regulatory hurdles that confront pharmaceutical companies and develops appropriate strategic options for clients to pursue.
